Phathom Pharmaceuticals

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$16,352
$7,324
$1,912
$682
Gross Profit
13,996
5,948
1,486
905
EBITDA
-70,796
-73,485
-65,470
-66,356
EBIT
-70,987
-73,682
-65,684
-66,541
Net Income
-85,577
-91,446
-82,852
-79,570
Net Change In Cash
16,352
7,324
1,912
682
Free Cash Flow
-63,487
-70,767
-69,060
-44,272
Cash
334,678
276,237
322,229
381,393
Basic Shares
64,627
58,558
58,371
51,289

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$682
$0
$0
$0
Gross Profit
515
-620
-521
-300
EBITDA
-159,049
-171,820
-134,559
-124,187
EBIT
-159,624
-172,440
-135,080
-124,487
Net Income
-201,592
-223,006
-148,094
-133,318
Net Change In Cash
682
0
0
0
Cost of Revenue
-104,237
43,731
Free Cash Flow
-139,214
-147,571
-148,945
-70,728
Cash
381,393
155,385
183,259
287,496
Basic Shares
51,289
39,118
37,002
33,228

Earnings Calls

Quarter EPS
2024-09-30
-$1.32
2024-06-30
-$1.56
2024-03-31
-$1.42
2023-12-31
-$1.39